Latest news

CoBioRes wants to participate in the 1000km from Kom op Tegen Kanker

  Where CoBioRes is dedicated to valorize promising and innovative research on a daily basis, we now have committed ourselves to exceed the scientific comfort...

Read more

CoBioRes receives a € 1.7M grant from VLAIO to support its tetrapeptide prodrug research for treatment of Triple Negative Breast Cancer

Leuven, Belgium/ May 22, 2018 / CoBioRes NV, an early stage biotech company that valorises promising academic research in the field of medicine by translating it into...

Read more
History of capital

History of capital

The history of the share capital issuance since the inception of CoBioRes can be found here:

Read more